Cardiology Flashcards
Define stable angina pectoris
A symptom of ischaemic heart disease. Central crushing pain due to decreased coronary artery blood flow causing oxygen supple/demand mismatch in exertion.
Describe the aetiology for stable angina pectoris
Narrowing of coronary artery by atherosclerosis. Rare: reduced o2 carrying capacity (anaemia), peripheral resistance (LV hypertrophy), coronary artery spasm (Prinzmetal angina)
What are the risk factors for stable angina pectoris
Non-modifiable: age, gender, race.
Modifiable: diabetes, hypertension, obesity high LDL, smoking
Describe the pathophysiology for stable angina pectoris
High oxygen demand on exertion. Narrowing of coronary arteries from atherosclerotic plaque reduces blood flow > myocardial ischaemia > angina
Atherogenesis: fatty streak > intermediate lesions > fibrous plaque
What are the key presentations for stable angina pectoris
Central crushing chest pain which can radiate to jaw, neck, arms, relieved with GTN spray or 5 min rest, pain brought on by exertion
Describe the symptoms for stable angina pectoris
Dyspnoea, nausea, sweating, fainting
What is the gold standard investigation for stable angina pectoris
CT angiography (presence of luminal narrowing, plaques)
Describe the first line investigations for stable angina pectoris
ECG (normal)
Other: Echocardiogram, exercise tolerance test (induces ischaemia), invasive angiography (shows pressure gradient across stenosis), bloods – lipid profile, HbA1c
What are the differential diagnosis for stable angina pectoris
Unstable angina, STEMI, NSTEMI
Describe the management for stable angina pectoris
Immediate symptomatic relief – GTN spray
Long term relief: 1st line – education. Beta blockers and/or CCB (amlodipine. Do not combine BB with non-dihydropyridine CCB). + other antianginal (long-acting nitrates, e.g. isosorbide mononitrate)
Procedural intervention: PCI, CABG
Secondary prevention: Aspirin, Atorvastatin, ACE inhibitor
Describe the complications for stable angina pectoris
MI, stroke, heart failure
Define unstable angina
Acute coronary syndrome includes unstable angina and myocardial infarction (STEMI, NSTEMI). Unstable angina is myocardial ischaemia at rest or on minimal exertion with the absence of myocardial injury. It is not relieved with GTN or rest.
Describe the aetiology for unstable angina
Atherosclerotic plaque rupture and subsequent thrombosis and inflammation
What are the risk factors for unstable angina
Non-Modifiable: age, gender, race. Modifiable: diabetes, hypertension, obesity, high LDL, smoking
Describe the pathophysiology for unstable angina
Atheroslerotic plaque rupture and thrombus forms around the ruptured plaque causing partial occlusion of the minor coronary artery causing reduced blood flow > myocardial ischaemia > angina
Describe the key presentations for unstable angina
Central crushing chest pain radiating to arms neck jaw, not relieved by GTN or rest, persists longer than 20 minutes, crescendo chest pain (frequent, easier to provoke)
Describe the clinical manifestations for unstable angina
Sweating, dyspnoea, nausea, fainting, palpitations
What is the gold standard investigation for unstable angina
ECG (no ST elevation) + biomarkers (no troponin increase)
Describe the first line investigations for unstable angina
History, ECG (normal or ST depression and T wave inversion), biomarkers (no increases in troponin)
Other: CT angiography
What are the differential diagnosis for unstable angina
Stable angina, pericarditis, myocarditis
Describe the management for unstable angina
Immediate management – MONA (morphine, oxygen <92%, nitrates, aspirin)
GRACE score (6 month risk of death or repeat MI after NSTEMI),
Prevention: aspirin, clopidogrel (antiplatelet), statin (atorvastatin), metoprolol (BB or CCB), ACEi, modify risk factors
High risk: angiography and PCI
What are the complications for unstable angina
MI, stroke, heart failure
Define a STEMI
ST elevated myocardial infarction is part of ACS. Ischaemic event leading to death of heart tissue and troponin release.
Describe the aetiology for a STEMI
Rupture and thrombosis of plaque causing complete occlusion of major coronary artery lumen.
Describe the risk factors for a STEMI
Non-modifiable: age, gender, race. Modifiable: hypertension, diabetes, obesity, high LDL, smoking
Describe the pathophysiology for a STEMI
Atherosclerotic plaque rupture and thrombosis causes complete occlusion of coronary artery leading to transmural injury and infarct to the myocardium.
What are the key presentations for a STEMI
Central crushing chest pain radiating down arms jaw neck, not relieved by rest or GTN spray, persists >20 mins, impending doom feeling
Describe the clinical manifestations for a STEMI
Signs: Tachycardia, high/low BP, 4th heart sound
Symptoms: Sweating, N+V, dyspnoea, fatigue, palpitations
What is the gold standard investigation for a STEMI
ECG (ST elevation) + biomarkers (troponin elevated)
Describe the first line investigations for a STEMI
ECG (ST elevation in anterolateral leads. After some time, T wave inversion, deep broad Q waves. Left bundle branch block), biomarkers (troponin elevated).
Other: CT angiography, bloods
What are the differential diagnosis for a STEMI
Unstable angina, NSTEMI, pericarditis
Describe the management for a STEMI
Acute treatment: MONA (morphine, oxygen <92%, nitrates, aspirin)
Primary PCI if available within 120minutes of first medical contact or within 12hours of symptoms, if unavailable, fibrinolysis to break down clot (e.g., alteplase)
Secondary prevention: aspirin, clopidogrel (antiplatelet), statin (atorvastatin), metoprolol (BB or CCB), ACEi, modify risk factors
What are the complications for a STEMI
Heart failure, rupture of infarcted ventricle, rupture of interventricular septum, heart block, arrhythmias, mitral regurgitation, post-MI pericarditis (Dressler’s syndrome)
Define an NSTEMI
Non-ST-elevated myocardial infarction is part of ACS. Acute ischaemic event causing myocardial cell necrosis and troponin release.
Describe the aetiology of an NSTEMI
Rupture and thrombosis of atherosclerotic plaque causing partial occlusion of major coronary artery or total occlusion of minor coronary artery.
Describe the risk factors for an NSTEMI
Non modifiable: age, gender, race. Modifiable: hypertension, diabetes, obesity, high LDL, smoking
Describe the pathophysiology for an NSTEMI
Atherosclerotic plaque rupture and thrombosis causes partial occlusion to coronary artery. This causes necrosis of cardiac tissue and infarction to sub endothelium.
What are the key presentations for an NSTEMI
Central crushing chest pain radiating down arms jaw neck, not relieved by rest or GTN spray, persists >20 mins, impending doom feeling
Describe the clinical manifestations for an NSTEMI
Signs: Tachycardia, high/low BP, 4th heart sound
Symptoms: Sweating, N+V, dyspnoea, fatigue, palpitations
What is the gold standard investigation for an NSTEMI
ECG (ST depression) + biomarkers (elevated troponin)
Describe the first line investigations for an NSTEMI
1st line: ECG (ST depression, T wave inversion. Also, transient ST elevation, R wave regression and biphasic T waves), biomarkers (troponin elevated)
Other: CT angiography, bloods
What are the differential diagnosis for an NSTEMI
STEMI, unstable angina
Describe the management for an NSTEMI
Immediate management – MONA (morphine, oxygen <92%, nitrates, aspirin)
Then: invasive coronary angiography and PCI
GRACE score (6-month risk of death or repeat MI after NSTEMI),
Prevention: aspirin, clopidogrel (antiplatelet), statin (atorvastatin), metoprolol (BB or CCB), ACEi, modify risk factors
Describe the complications for an NSTEMI
Heart failure, ruptured infarcted ventricle, ruptured interventricular septum, mitral regurgitation, arrhythmias, heart block, post-MI pericarditis (Dressler syndrome)
Describe the types of MI
Type 1: Traditional MI due to an acute coronary event
Type 2: Ischaemia secondary to increased demand or reduced supply of oxygen (e.g. secondary to severe anaemia, tachycardia or hypotension)
Type 3: Sudden cardiac death or cardiac arrest suggestive of an ischaemic event
Type 4: MI associated with procedures such as PCI, coronary stenting and CABG
ACDC
Type 1: A – ACS-type MI
Type 2: C – Can’t cope MI
Type 3: D – Dead by MI
Type 4: C – Caused by us MI
Define heart failure
Heart failure is the inability of the heart to deliver oxygenated blood to tissues at a satisfactory rate for the tissues metabolic requirements.
Systolic heart failure: failure of heart to contract efficiently to eject adequate volumes of blood. Ejection fraction <40%. Heart failure with reduced ejection fraction. HFrEF
Diastolic heart failure: inability of the ventricles to relax and fill normally, causing increased filling pressures. Ejection fraction >50%. Heart failure with preserved ejection fraction. HFpEF
Right heart failure: inability of the right ventricle to pump adequate amount of blood leading to systemic venous congestion.
Left heart failure: inability of left ventricle to pump adequate amount of blood leading to pulmonary circulation congestion and oedema.
Describe the epidemiology for heart failure
10% of over 70s, male > women, increases with age, typical effects 1-2% developed world
Describe the aetiology for heart failure
Ischaemic heart disease, hypertension, cardiomyopathy, alcohol excess, valve disease
Right heart failure: pulmonary hypertension, pulmonary embolism, COPD, cor pulmonale (right heart enlargement as a result of disease of lungs or blood vessels)
Left heart failure: coronary artery disease, valve defect, myocardial infection, congenital heart defects, arrhythmias
Describe the risk factors for heart failure
Older, male, smoking, obesity, previous MI
Describe the pathophysiology for heart failure
Stroke volume requires adequate preload, optimal myocardial contractility (Frank-starling mechanism), decreased afterload. Therefore reduced cardiac output (heart failure) can be caused by decreased preload, decreased contractility, increased afterload, decreased heart rate.
Once the heart begins to fail compensatory changes occur to maintain CO: increased SNS (increases HR and contractility), increased RAAS (increased fluid retention = increased preload), natriuretic peptides (diuretic, hypotensive, vasodilators), ventricular dilation, ventricular hypertrophy.
Compensatory mechanisms become exhausted and pathological: SNS and RAAS also cause vasoconstriction which increases afterload and myocardial work. Increased cardiac work damages the myocytes reducing CO = heart failure
What are the key presentations for heart failure
SOB, fatigue and oedema
Describe the clinical manifestations for heart failure
Signs: Oedema (LHF = pulmonary congestion – pulmonary oedema, RHF = systemic backlog – peripheral oedema)
LHF: bibasal pulmonary crackles, 3rd and 4th heart sounds, cardiomegaly (displaced apex beat), tachycardia
RHF: raised JVP, hepatomegaly, pitting oedema, weight gain (fluid)
Symptoms: LHF: dyspnoea, orthopnoea, paroxysmal nocturnal dyspnoea, poor exercise tolerance, fatigue, nocturnal cough (pink frothy sputum), wheeze, cold peripheries
RHF: peripheral oedema, ascites, nausea, anorexia, facial engorgement, epistaxis
What is the gold standard investigation for heart failure
Echocardiogram (may confirm cause, e.g., MI, valvular heart disease, and can show LV dysfunction)
Describe the first line investigations for heart failure
1st line: ECG (abnormal – may indicate cause, e.g., ventricular hypertrophy), BNP (brain natriuretic peptide – elevated. Released from myocardial walls under stress). Chest x-ray (ABCDE – alveolar oedema, Kerley B lines, cardiomegaly, dilated upper lobe vessels, effusions (pleural)
Other: FBC
What are the differential diagnosis for heart failure
COPD, pulmonary embolism
Describe the management for heart failure
1st line - ABAL. ACE inhibitor (ramipril), beta blocker (bisoprolol), aldosterone antagonist (spironolactone), loop diuretic (furosemide)
Consider cardiac resynchronisation therapy. Surgery: LVAD, cardiac transplantation
What are the complications for heart failure
Pleural effusion, acute kidney injury, sudden cardiac death
Describe the prognosis for heart failure
50% die within 5 years of diagnosis
Define hypertension
Blood pressure >140/90 in clinic, >135/85 with ambulatory or home readings
Describe the epidemiology for hypertension
Biggest risk factor for cardiovascular disease
Describe the aetiology for hypertension
- Essential hypertension (95%) - idiopathic
- Known cause (5%) – ROPED renal disease, obesity, pregnancy/pre-eclampsia, endocrine syndrome (Conn’s), Drugs (alcohol, steroids, NSAIDS, oestrogen and liquorice)
Describe the risk factors for hypertension
Non-modifiable: age, FHx, ethnicity (Afro-Caribbean). Modifiable: alcohol, sedentary lifestyle, diabetes, smoking, salt intake
Describe the pathophysiology for hypertension
Causes of hypertension will increase RAAS and SNS causing increased cardiac output and total peripheral resistance, and therefore increase in blood pressure. BP = CO x TPR
What are the key presentations for hypertension
Asymptomatic
Describe the clinical manifestations for hypertension
Malignant hypertension (180/120): headache, visual disturbances, chest pain, seizures.
Also look for secondary causes of HTN: renal disease, phaeochromocytoma, Cushing’s coarctation of aorta
What is the gold standard investigation for hypertension
Ambulatory BP (worn 24hrs) > 135/85 mmHg
Describe the first line investigations for hypertension
Clinic BP >140/90 mmHg
Stage Clinic BP ABPM BP
1 >140/90 >135/85
2 >160/90 150/95
3 >180/120*
Other: Fundoscopy (HTN retinopathy), urine albumin:creatinine (proteinuria) and dipstick (haematuria) for renal failure, bloods (HbA1c, GFR, lipids), ECG (abnormalities)
What are the differential diagnosis for hypertension
Chronic kidney disease, Cushing syndrome, phaeochromocytoma
Describe the management for hypertension
- T2DM or Age <55 = ACEi (or ARB). Age > 55 or Black-African/Afro-Caribbean origin = CCB
- ACEi + CCB
- ACEi + CCB + thiazide-like diuretic
- If potassium <4.5 = 1,2,3 + spironolactone. If potassium >4.5 = 1,2,3 + alpha or beta blocker
Note: If T2DM + Black/Afro + age >55, diabetes takes precedence so give ACEi
Describe the monitoring for hypertension
Treatment targets: Age <80 = <140/90mmHg. Age >80 = <150/90mmHg
Describe the complications for hypertension
Ischaemic heart disease, cerebrovascular event (stroke, MI), heart failure, CKD
Define Cor Pulmonale
Right sided heart failure caused by respiratory disease
Describe the aetiology for Cor Pulmonale
COPD, pulmonary embolism, interstitial lung disease, cystic fibrosis, primary pulmonary hypertension
Describe the risk factors for Cor Pulmonale
Respiratory disease
Describe the pathophysiology for Cor Pulmonale
Increased pressure and resistance in the pulmonary arteries (pulmonary hypertension) results in the right ventricle being unable to effectively pump blood out of the ventricle and into the pulmonary arteries. This leads to back pressure of blood in the right atrium, the vena cava and systemic venous system.
What are the key presentations for Cor Pulmonale
SOB, peripheral oedema, chest pain
Describe the clinical manifestations for Cor Pulmonale
Signs: Hypoxia, cyanosis, raised JVP, peripheral oedema, 3rd heart sound, murmurs (e.g., pan-systolic in tricuspid regurgitation), hepatomegaly
Symptoms: Shortness of breath, syncope, dizziness,
What is the gold standard investigation for Cor pulmonale
Right heart catheterisation
Describe the first line investigations for Cor Pulmonale
ABG (hypoxia and hypercapnia), spirometry, chest CT, echocardiogram
What are the differential diagnosis for Cor Pulmonale
Primary pulmonary hypertension, pulmonary valve stenosis
Describe the management for Cor Pulmonale
Treat symptoms and underlying cause. Long term oxygen therapy. Treat heart failure (ABAL). Consider venesection (reduces RBCs) if haematocrit > 55. Consider heart-lung transplantation in young patients
Describe the complications for Cor Pulmonale
Tricuspid regurgitation, hepatic congestion and cardiac cirrhosis, death
Describe the prognosis for Cor Pulmonale
50% 5 year survival
Define atrial fibrillation
Atrial fibrillation is a supraventricular tachycardia caused by uncoordinated, rapid and irregular atrial activity, resulting in an irregularly irregular ventricular pulse
Describe the epidemiology for AF
Most common sustained cardiac arrhythmia, more males than females
Describe the aetiology for AF
Heart failure, hypertension, coronary artery disease, valvular disease (especially mitral valve stenosis), cardiac surgery, cardiomyopathy, idiopathic
Describe the risk factors for AF
Age 60+, hypertension, T2DM, heart failure, past MI
Describe the pathophysiology for AF
Contraction of the atria is uncoordinated, rapid and irregular due to disorganised electrical activity which overrides the sinoatrial node activity. 300-600bpm.
What are the key presentations for AF
Irregular pulse, tachycardia, palpitations, ECG: no P waves, irregularly irregular pulse and narrow QRS
Describe the clinical manifestations for AF
Signs: Irregularly irregular ventricular contractions, tachycardia, apical pulse > radial rate, thromboembolism. ECG: no P waves, irregularly irregular pulse with narrow QRS
Symptoms: Asymptomatic, chest pain, palpitations, dyspnoea, fainting
What is the gold standard investigation for AF
ECG: absent P waves, irregularly irregular pulse (irregular R-R intervals with narrow QRS)
Describe the first line investigations for AF
1st line ECG: absent P waves, irregularly irregular pulse (irregular R-R intervals with narrow QRS)
Other: FBC
What are the differential diagnosis for AF
Atrial flutter, Wolff-Parkinson-white syndrome, atrial tachycardia
Describe the management for AF
1st line haemodynamically unstable – DC direct current cardioversion (shocks AF to sinus rhythm)
1st line haemodynamically stable - rate control beta blockers (bisoprolol/metoprolol) or CCB (verapamil/diltiazem) + digoxin. Also, rhythm control with electrical or pharmacological (flecainide) cardioversion + pre-cardioversion anticoagulant.
Long term: catheter ablation
Describe the monitoring for AF
CHA2DS2-VASc score calculates stroke risk for atrial fibrillation patients. It includes: congestive heart failure, hypertension, age >75 x2, diabetes, stroke x2, vascular disease, age 65-74, sex category (female). If the score is <2, anticoagulant is required.
Describe the complications for AF
Acute stroke, myocardial infarction, congestive heart failure
Describe the prognosis for AF
Double mortality risk and 5x stroke risk
Define atrial flutter
Macro re-entrant atrial tachycardia caused by organised electrical activity in the atrium with a rate of 250-350bpm. Less common than AF
Describe the aetiology of atrial flutter
Idiopathic, coronary heart disease, obesity, heart failure, hypertension, COPD, pericarditis
Describe the risk factors for atrial flutter
AF
Describe the pathophysiology for atrial flutter
Originates from a re-entrant circuit around the tricuspid valve annulus. Short circuit causes the atria to fire very rapidly
What are the key presentations for atrial flutter
ECG: flutter waves saw-tooth pattern, often 2:1 block (p-wave: QRS complex)
Describe the clinical manifestations for atrial flutter
Signs: ECG: saw-tooth pattern (F waves), often 2:1 block (2 P waves for every QRS), tachycardia (above 150bpm)
Symptoms: Palpitations, dyspnoea, chest pain, dizziness, syncope, fatigue
What is the gold standard investigation for atrial flutter
ECG: saw-tooth pattern (flutter waves), often 2:1 block (2 P waves for every QRS)
Describe the first line investigations for atrial flutter
ECG: saw-tooth pattern (flutter waves), often 2:1 block (2 P waves for every QRS)
Other FBC
What are the differential diagnosis for atrial flutter
Atrial fibrillation, atrial tachycardia
Describe the management for atrial flutter
Haemodynamically unstable – DC cardioversion
Haemodynamically stable – 1. rate control (beta blocker) + anticoagulant (LMWH), 2. electrical cardioversion, 3. pharmacological cardioversion
Ongoing – catheter ablation (removes faulty electrical pathway)
Describe the monitoring for atrial flutter
CHA2SD2-VASc for risk of stroke in atrial fibrillation/flutter
Describe the complications for atrial flutter
Acute stroke, medication related bradycardia
Define heart block
AV block involves partial or complete interruption of impulse transmission from atria to ventricles. Types: 1st degree, 2nd degree Mobitz type 1, 2nd degree Mobitz type 2, 3rd degree (complete)
Describe the aetiology for heart block
Main: Coronary artery disease, cardiomyopathy, fibrosis
1st degree: AV blocking drugs (beta blockers, CCB, digoxin)
2nd degree Mobitz type 1: AV blocking drugs (beta blockers, CCB, digoxin, amiodarone), inferior MI
2nd degree Mobitz type 2: drugs, MI, rheumatic fever
3rd degree (complete): MI, hypertension, structural heart defect
Describe the risk factors for heart block
Coronary artery disease, cardiomyopathy, fibrosis
Describe the pathophysiology for heart block
1st degree: consistent prolongation of PR interval due to delayed conduction via AV node. Every P wave followed by a QRS
2nd degree Mobitz type 1: progressive prolongation of the PR interval until the atrial impulse is not conducted and a QRS complex is dropped. AVN conduction begins with next beat and sequence repeats. Wenckebach phenomenon.
2nd degree Mobitz type 2: consistent prolonged PR interval duration with intermittently dropped QRS complexes due to failure of conduction. PR interval is constant, but every 3rd/4th QRS is dropped.
3rd degree (complete): no communication between atria and ventricles due to complete failure of conduction. P waves and QRS complexes have no association due to atria and ventricles functioning independently.
What are the key presentations for heart block
1st degree: asymptomatic.
2nd degree Mobitz type 1: asymptomatic/ bradycardia, syncope, irregular pulse
2nd degree Mobitz type 2: palpitations, syncope, regular irregular pulse
3rd degree (complete): palpitations, syncope, irregular pulse, bradycardia, chest pain, shortness of breath
Describe the gold standard investigations for heart block
1st degree: ECG: every P followed by QRS, prolonged PR(>200ms), regular rhythm
2nd degree Mobitz type 1: ECG: Progressive lengthening of PR interval until a QRS is dropped and cycle repeats with shorter PR interval, irregular rhythm
2nd degree Mobitz type 2: ECG: Constant enlarged PR interval, but every nth QRS complex is missing, irregular rhythm
3rd degree (complete): ECG: P waves and QRS complexes random. PR interval absent due to atria-ventricle dissociation.
Other investigations: troponin (may be elevated)
What are the differential diagnosis for heart block
SVT, AF
Describe the management for heart block
1st degree: asymptomatic = no treatment, symptomatic = pacemaker
2nd degree Mobitz type 1: asymptomatic = no treatment, symptomatic = pacemaker
2nd degree Mobitz type 2: pacemaker
3rd degree (complete): IV atropine/isoprenaline + permanent pacemaker
Describe the complications for heart block
Sudden cardiac death
Define ventricular ectopics
Premature ventricular beats caused by random electrical discharges from the ventricles before an electrical impulse can be made by the atrium
What are the key presentations for ventricular ectopics
Random, brief palpitations, abnormal beat, syncope
What is the gold standard investigation for ventricular ectopics
ECG: individual random, abnormal, broad QRS complexes on a background of a normal ECG
Describe the management for ventricular ectopics
Reassurance and self-monitoring. Beta blocker or CCB. Ablation to stop abnormal signals
Describe the complications for ventricular ectopics
Bigeminy - ventricular ectopics occur so frequently that they happen after every sinus beat. ECG shows normal sinus beat followed by ectopic, normal, ectopic
Define long QT syndrome
Ventricular tachyarrhythmia characterised by prolonged QT interval on ECG >480ms
Describe the aetiology for long QT syndrome
Congenital channelopathy: Romano-Ward syndrome, hypokalaemia, hypocalcaemia, bradycardia, drugs (amiodarone, tricyclic antidepressants)
What are the key presentations for long QT syndrome
Syncope, palpitations, may progress to V-fib
What is the gold standard investigation for long QT syndrome
ECG: prolonged QT interval >480ms
Describe the management for long QT syndrome
Correct electrolyte disturbances and remove causative factors, give beta blocker, pacemaker or implantable defib
Describe the complications for long QT syndrome
Torsades de pointes
Define Wolff-Parkinson-White syndrome (AVRT)
AVRT- atrioventricular re-entry tachycardia. There is an accessory pathway for impulse conduction caused by a congenital connection between the atria and ventricles. Not through the AV node.
Describe the aetiology for Wolff-Parkinson-White syndrome
Congential abnormality, Epstein’s anomaly
What are the risk factors for AVRT
Congenital heart defects
Describe the pathophysiology for AVRT
An accessory pathway between the atria and ventricles allows electrical conduction to bypass the AV node and for the ventricles to be stimulated pre-maturely. Alongside the AV node conduction, this leads to double exciting of the ventricles. The accessory pathway in WPW is called Bundle of Kent. As conduction is not regulated by the AV node, this causes tachycardia.
What are the key presentations for AVRT
Palpitations, ECG: short PR interval, wide QRS, slurred upstroke of QRS complex = delta wave
Describe the clinical manifestations for AVRT
Signs: Tachycardia, ECG: short PR interval, wide QRS, slurred upstroke of QRS complex = delta wave
Symptoms: Palpitations, dizziness, dyspnoea
What is the gold standard investigation for AVRT
ECG: short PR interval, wide QRS, slurred upstroke of QRS complex = delta wave
Describe the first line investigations for AVRT
ECG: short PR interval, wide QRS, slurred upstroke of QRS complex = delta wave
What are the differential diagnosis for AVRT
AF, atrial flutter, AVNRT
Describe the management for AVRT
1st line – Vagal manoeuvre to slow heart: Valsalva manoeuvre (pinch nose, blow out of mouth) or carotid sinus massage
2. If unsuccessful give IV adenosine (slows conduction through heart. 6mg, then 12mg)
3. Cardioversion. Long term - catheter ablation (remove faulty electrical pathway)
Describe the complications for AVRT
Sudden cardiac death
Define abdominal aortic aneurysm
Dilation of the abdominal aorta >50% with a diameter greater than 3cm (aneurysm typically infrarenal)
Describe the epidemiology for AAA
Men affected more often and younger
Describe the aetiology of AAA
Mainly idiopathic, atheroma, trauma, infection, connective tissue disorders (Marfan’s and Ehlers-Danlos syndrome)
Describe the risk factors for AAA
Smoking, atherosclerosis, obesity, hypertension, increasing age
Describe the pathophysiology for AAA
Inflammation and degeneration of smooth muscle cells > loss of structural integrity of the aortic wall > widening of the vessel > mechanical stress (e.g., hypertension) acts on weakened wall tissue > dilation and rupture may occur
Dilation of vessel may disrupt laminar flow and turbulence causing thrombi formation in the aneurysm and thromboembolism
What are the key presentations for AAA
Asymptomatic, palpable pulsatile abdominal mass
Describe the clinical manifestations for AAA
Signs: Pulsatile mass on abdomen palpitation, bruit, hypotension, tachycardia
Symptoms: Back pain, RUPTURE = severe epigastric pain radiating to back and flank, loss of consciousness, N+V, painful pulsatile mass, hypovolemic shock
What is the gold standard investigation for AAA
Computed tomography angiography
Describe the first line investigations for AAA
1st line Abdominal Ultrasound (>3cm. ruptured = immediate management)
What are the differential diagnosis for AAA
Acute pancreatitis, diverticulitis, appendicitis
Describe the management for AAA
Ruptured = emergency. Urgent surgical repair EVAR (endovascular aneurysm repair, stent inserted through femoral arteries) or open surgical repair. + resuscitation measures (oxygen, fluids, catheter, permissive hypotension – aiming for lower-than-normal BP during fluid resuscitation as higher BP may increase blood loss)
Unruptured: symptomatic = urgent surgical repair. Asymptomatic = surveillance and risk management (smoking, diet, exercise, HTN). If asymptomatic but aneurysm > 5.5cm or rapidly growing = elective surgical repair. EVAR or open surgery
What are the complications for AAA
Ruptured aneurysm, thrombosis, embolism, abdominal compartment syndrome
Describe the prognosis for AAA
80% mortality if ruptured
Define aortic dissection
Tear in the intima of the aorta allowing blood to flow dissect the media, forming a false lumen between the inner and outer layers of the media.
Stanford classification: Type A – affects ascending aorta before brachiocephalic artery. Type B – affects descending aorta after the left subclavian. Most common location: sinotubular junction where aortic roots becomes tubular aorta (type A)
Describe the epidemiology of aortic dissection
Men aged 50-70
Describe the aetiology for aortic dissection
Mechanical wall stress due to risk factors. Also, connective tissue disorders (Marfan’s and Ehlers-Danlos syndrome), and aorta conditions (bicuspid aortic valve, coarctation of the aorta, CABG)
Describe the risk factors for aortic dissection
Hypertension, smoking, trauma, raised LDL, obesity, sedentary lifestyle, male, increasing age.
Describe the pathophysiology for aortic dissection
Tear in the intima causes blood to pass through the media creating a false lumen. As the dissection spreads, flow through the false lumen can occlude flow through branches of the aorta including coronary, brachiocephalic, carotid, intercostal, renal and visceral > ischemia of supplied regions.
What are the key presentations for aortic dissection
Sudden and severe ripping/tearing pain in chest
Describe the clinical manifestations for aortic dissection
Signs: Asymmetrical blood pressure in arms (>20mmHg), hypotension, radial pulse deficit (radial pulse in one arm is decreased/absent and doesn’t match apex beat), diastolic murmur, focal neurological deficit (e.g., muscle weakness/paralysis – carotid and spinal arteries), interscapular and lower pain
Symptoms: Syncope, chest, and abdominal pain, muscle weakness
What is the gold standard investigation for aortic dissection
CT angiogram or transoesophageal echocardiogram (intimal flap and false lumen)
Describe the first line investigations for aortic dissection
1st line ECG (ST depression may occur), chest x-ray (widened mediastinum), TTE echocardiogram (intimal flap in acute, two lumens in chronic)
Other: MRI
What are the differential diagnosis for aortic dissection
Myocardial infarction, cardiac arrest, pericarditis
Describe the management for aortic dissection
1st line – immediate surgery. Type A (open surgery to replace aortic defect with stent), Type B (TEVAR thoracic endovascular aortic repair). Maintain haemodynamic stability (fluids, adrenaline, transfusion)
Medical: 1. Beta blocker (labetalol), or, 2. Non-dihydropyridine CCB (diltiazem/verapamil). Also, vasodilator sodium nitroprusside
Describe the complications for aortic dissection
Cardiac tamponade, aortic regurgitation, pre-renal AKI
Describe the prognosis for aortic dissection
High mortality from rupture